In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
Ajinomoto combines two biotech ingredients in futuristic latte
In Singapore, iced lattes made from beanless coffee and cow-free proteins pulled from air will be available shortly in a preview at the country’s...
San Fran hotspot Fiorella hosts Mission Barns’ first cultivated pork sale
In California, cultivated meat maker Mission Barns has sold its pork for the first time at an exclusive dinner at San Francisco hot spot...
Uluu raises $10.4M to scale seaweed-based plastic
In Australia, seaweed-based plastic startup Uluu has raised AU$16 million (US$10.4 million) to build a demonstration plant to prove the viability of its technology.
Uluu’s...